Akebia Therapeutics, Inc. (AKBA) Q2 2019 Earnings Call Transcript
AKBA earnings call for the period ending June 30, 2019.
Akebia Therapeutics
AKBA
AKBA
$4.78
-$0.32
-6.3%
BATS BZX Real Time Price as of September 16, 2019, 4:00 p.m. EDT
View Interactive AKBA Charts
AKEBIA THERAPEUTICS INC COM USD0.00001
News & Analysis: Akebia Therapeutics
Akebia Therapeutics, Inc. (AKBA) Q1 2019 Earnings Call Transcript
AKBA earnings call for the period ending March 31, 2019.
Akebia Therapeutics (AKBA) Q4 2018 Earnings Conference Call Transcript
AKBA earnings call for the period ending December 31, 2018.
Why Akebia Therapeutics, Momo, and Switch Jumped Today
Good news on several fronts helped lift many stocks.
Why Akebia Therapeutics Is Soaring Today
Great news from two late-stage studies lit a fire under the biopharmaceutical stock.
Why Akebia Therapeutics Is Soaring Today
Traders cheer after the company completes its merger agreement. Here's what investors need to know.
Here's Why Keryx Biopharmaceuticals and Akebia Therapeutics Are Plunging Today
Shares of both companies tumble after the two entities announced the signing of a merger agreement. Here's what investors need to know.
Why Akebia Therapeutics Stock Is Skyrocketing Today
Akebia Therapeutics gets a sizable equity investment from Vifor Pharma as part of a supply agreement for the experimental anemia drug vadadustat.
Why Akebia Therapeutics Shares Soared 33.4% Today
An expanded licensing pact with Otsuka boosted investors' optimism.
Why Akebia Therapeutics Inc. Tanked Today
The development-stage biotech saw investors get skittish, and the reason may be that some of them hadn't done their homework.
